ABSTRACT Roles of nicotinic receptors in the dorsal motor nucleus of the vagus (DMV) in the regulation of gastric motility were investigated in urethane-anesthetized rats in which an intragastric balloon had been placed. Nicotine (0.1 nmole) microin jected into the DMV but not the nucleus ambiguus induced dual changes, a decrease followed by an increase in gastric motility. Administration of 0. 1 nmole of hexametho nium into the DMV significantly inhibited the decrease in gastric motility induced by intravenously administered nicotine.
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We recently reported that intracerebro ventricularly (i.c.v.) administered nicotine induced dual changes, a decrease followed by an increase in gastric motility in rats (1) and that this dual effect of i.c.v.-administered nicotine was reproduced by a 10 times smaller dose of intracisternally (L c.) -administered nicotine (2) . These findings suggest that the site of action of nicotine probably resides in the lower part of the brain, such as the brain stem. In the present study, therefore, possible roles of nicotinic receptors in the dorsal motor nucleus of the vagus (DMV) in central regula tion of gastric motility were investigated by administration of nicotine in rats.
Male Wistar rats weighing 350-400g were maintained in a room at 22 24°C under a constant day-night rhythm and given food (laboratory chow, CA-1; Clea, Inc., Japan) and tap water ad libitum. Prior to each experi ment, food was withheld for 24 hr but water was provided. Under anesthesia with urethane (1.2 g/kg, i.p.), a single femoral artery and vein were cannulated to monitor blood pres sure and to apply test substances, respectively.
Gastric motility was measured with a flaccid intragastric balloon inserted into the stomach through an incision in the fundus. After clo sure of the incision, 2 to 3 ml of water were introduced into the balloon to give an intra gastric pressure of about 100 mmH2O. Changes in intragastric pressure induced by gastric contraction were measured using a pressure transducer connected to the balloon, and a pen writing recorder was used to moni tor differences. All waves larger than 5 mmH2O in amplitude (1 mm of pen displace ment vertically) were counted as contractions. The mean amplitude was calculated for con secutive 2-min periods and was taken to indi cate the gastric motility.
Test substances given into the brain were dissolved in artificial cerebrospinal fluid (vehi cle), the composition of which was 7.3 mg NaCI, 1.9 mg NaHCO2, 0.3 mg MgSO4, 0.2 mg CaC12 and 0.2 mg NaH2PO4 in 1 ml of deionized water; i.e., a slight modification of the composition described by Falcon et al. (3) . The solutions containing test substances were then applied into the DMV and its adjacent area in a volume of 0.5 ,u l/animal through a glass micropipette (50 ,u m outer diameter). At the end of the experiment, the brain was re moved, fixed in 10% formalin, and the frozen sections sliced at 30 ,u m were stained with cresyl-violet for microscopic localization of the micropipette insertion site. Student's t-test was used for comparison between two groups, and Duncan's multiple range test was used for multiple comparison. P values of less than 5% were considered to be statistically significant.
When the intraluminal pressure applied was about 100 mmH2O, spontaneous and rhythmic contractions of the stomach with an amplitude of 93.6 ± 8.8 mmH2O (n = 34) were ob served. Because of relatively large individual variations, the results obtained were expressed as percent change of the basal value (the basal value being the mean of three values from the triplicate 2-min periods preceding administra tion of nicotine).
When the tip of micropipette had been placed in an area within 200 ,um from the DMV, 0.1 nmole of nicotine induced dual changes, a decrease followed by an increase in gastric motility with no exceptions (n = 7) (Fig. 1 ). When the micropipette had been placed at a site far from the DMV, more than about 200,um away, in 5 out of 7 instances, 0.1 nmole of nicotine did not induce any changes in gastric motility. In the other 2 in stances, micropipette had passed through the DMV. Therefore, a result obtained from the experiment in which the micropipette tip had been placed in an area within 200 ,um from the DMV was totalized as that by administra tion of nicotine into the DMV. Nicotine (0.01 nmole) administered into the DMV produced only a decrease in gastric motility. One-half microliter of artificial cere brospinal fluid (vehicle) given into the DMV had no significant effects on gastric motility (Fig. 1) .
Administration 0.1 nmole of nicotine into the DMV elicited dual changes, a decrease followed by an increase in gastric motility. These dual changes were comparable to those by administration of nicotine intracisternally (i, c. ), but the effective dose of nicotine admin istered into the DMV was 100 times smaller than that of nicotine administered i.e. (2). It is well-known that the cell bodies of the pre ganglionic neurons of the gastric vagus nerve are found in the nucleus ambiguus as well as the DMV (4). When nicotine was adminis tered into the nucleus ambiguus, gastric motil ity was, however, not significantly affected. These results suggest that nicotinic receptors in the DMV but not the nucleus ambiguus are involved in the effects of centrally adminis tered nicotine on gastric motility. In contrast to the dual changes, a decrease followed by an increase in gastric motility elicited by a higher dose of nicotine, only a decrease in gastric motility was induced by a lower dose of this alkaloid administered into the DMV. These results reveal that a larger dose of nicotine is required for inducing an increase rather than a decrease in gastric motility. The vagus nerve has two efferent components, one inhibitory and the other excitatory to the stomach. The decrease and the increase in gastric motility induced by i.c.v.-administered nicotine are mediated by the vagal inhibitory and excita tory components, respectively (1). Both cen tral inhibitory and excitatory influences to the stomach are finally integrated in the DMV and conveyed with the vagus nerve. There fore, different neuronal sensitivities of vagal inhibitory and excitatory mechanisms in the DMV to nicotine may explain the inability of a lower dose of nicotine to increase gastric motility.
We suggested that a smaller dose of nicotine administered intravenously (i.v.) activated nicotinic receptors in the brainstem and elic ited vagally-mediated inhibition of gastric motility (2) . In the present study, we ex amined whether or not nicotinic receptors within the DMV participated in inhibition of gastric motility induced by i.v.-administered nicotine. Nicotine at 300 nmole/kg adminis tered i.v. decreased gastric motility, as pre viously reported (2) . No significant changes in blood pressure were observed by i.v.-adminis tered nicotine. In the animals in which bilater al DMV were pretreated with 0.1 nmole hex amethonium, the decrease in gastric motility induced by i.v. administered nicotine was sig nificantly inhibited (Fig. 2) . These results sug gest that the DMV-mediated central inhibition of gastric motility is manifestable by in travenous administration of this alkaloid. Fig. 2 . Effect of hexamethonium on the decrease in gastric motility induced by intravenously (i.v.) admin istered nicotine. 0, vehicle (CSF) plus nicotine (n = 6); •, hexamethonium, 0.1 nmole plus nicotine (n = 7). DMV, administration of hexamethonium or vehicle into the bilateral DMV. i.v., intravenous administra tion of nicotine, 300 nmole/kg. The results are expressed as means ± S.E. a, p < 0.01 (significantly differ ent from the respective value just before administration of nicotine). r', P < 0.01 (significantly different from the corresponding values pretreated with vehicle alone).
In the next series, the effect of nicotine mi croinjected into the hypothalamic regions was examined. We reported that administration 3 nmole of nicotine into the posterior part of the ventromedial nucleus of the hypothalamus significantly increased gastric acid output (5) .
In the present study, however, no significant changes in gastric motility was observed with 3 nmole of nicotine applied into various parts of the hypothalamus (the anterior nucleus, the paraventricular nucleus, the ventromedial nu cleus, the dorsomedial nucleus, the posterior nucleus and the premamillary nucleus) (data not shown). Therefore, different from the effect of nicotine on gastric acid secretion, there is little possibility that this alkaloid administered into the hypothalamus produces any changes in gastric motility.
In conclusion, we demonstrated that nicotin ic receptors in the DMV are involved in cen tral regulation of gastric motility. However, involvement of nicotinic receptors in the soli tary nucleus in nicotine-induced changes in gastric motility can not be ruled out, since the DMV and the solitary nucleus are in close proximity, and there exists a functional circuit between these two nuclei.
